IP Library Granted Patent US 7,754,880
Granted Patent B2
US 7,754,880 · App. 10/536,485 · Granted Jul 13, 2010

Uracils having a herbicidal activity

Assignee: Isagro Ricerca S.r.l.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,754,880
App. No.
10/536,485
Granted
Jul 13, 2010
Kind
B2
Abstract

New uracils are described, having general formula (I) and their use as herbicides.

Claims (90)

1. A compound having formula (I):

wherein:

X 1 represents a hydrogen atom or a halogen atom;

X 2 represents a halogen atom;

X 4 represents a C 1 -C 3 haloalkyl group;

R represents a hydrogen atom, a C 1 -C 3 alkyl group or a C 1 -C 3 haloalkyl group;

G represents an oxygen atom or a sulphur atom;

X 3 represents a Q(CR 1 R 2 ) n Z— group, a Q 2 - group, a Y (CO)—CR 6 ═CR 5 —CR 3 R 4 Z— group;

Z represents an oxygen atom or a sulphur atom;

R 1 , R 2 , R 3 and R 4 , the same or different, represent a hydrogen atom or, a C 1 -C 4 alkyl group;

R 5 represents an OR 7 group;

R 6 represents a hydrogen atom or a C 1 -C 4 alkyl group;

R 7 represents a C 1 -C 4 alkyl group or a C 1 -C 4 haloalkyl group;

Y represents a C 4 -C 6 alkoxy or haloalkoxy group;

n represents 1, 2 or 3;

Q represents a heterocyclic group selected from 1,3,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,2,4-thiadiazolyl and 1,2,4-oxadiazolyl, said groups, in turn, being optionally substituted with a halogen atom selected from chlorine, fluorine, bromine or iodine, or with a group selected from C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl or C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl,

Q 2 represents a heterocyclic group selected from 1H-tetrazol-5-yl or 2H-tetrazol-5-yl, being optionally substituted with a group selected from: C 1 -C 6 alkyl; C 1 -C 6 haloalkyl; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 2 -C 6 alkynyl; C 2 -C 6 haloalkynyl, C 2 -C 6 alkoxyalkyl; C 2 -C 6 haloalkoxyalkyl; C 3 -C 8 alkoxyalkoxyalkyl, C 6 -C 12 arylalkyl, C 7 -C 12 aryloxyalkyl, C 8 -C 12 arylalkyloxyalkyl said groups in turn being optionally substituted with halogen atoms, C 1 -C 4 alkyl groups, C 1 -C 3 haloalkyl groups, C 1 -C 4 alkoxy groups, C 1 -C 3 haloalkoxy groups, CN; C 3 -C 7 cycloalkyl, C 6 -C 12 cycloalkylalkyl, tetrahydropyran-2-yl said groups in turn being optionally substituted with halogen atoms, C 1 -C 4 alkyl groups, C 1 -C 4 alkoxy groups.

2. A compound according to claim 1 , characterized in that it is selected from:

methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

methyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenylthio}-3-methoxybut-2-enoate;

ethyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrehydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-ethoxybut-2-enoate;

methyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenylthio}-3-methoxybut-2-enoate;

ethyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-ethoxybut-2-enoate;

isopropyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

methyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

ethyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-ethoxybut-2-enoate;

isopropyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

2,2,2-trifluoroethyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

2,2,2-trifluoroethyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

3-{5-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methoxy]-4-chloro-2-fluorophenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(2-methyl-2H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(1-methyl-1H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2, 4(1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(2-methyl-2H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(2-methyl-2H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2, 4 (1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(2-methyl-2H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(1-methyl-1H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(1-methyl-1H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(2-methyl-2H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(2-methyl-2H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3- [4-chloro-3-(2-ethyl-2H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(1-methyl-1H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(1-methyl-1H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[2,4-dichloro-5-(1-methyl-1H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(1-ethyl-1H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

methyl (2E)-4-{(2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-6-oxo-2-thioxo-4-(trifluoromethyl)pyrimidin-1-yl]-phenoxy}-3-methoxybut-2-enoate;

methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-difluoromethyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

methyl(2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxypent-2-enoate;

methyl(2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxypent-2-enoate;

ethyl (2E)-4-{2,4-dichloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

ethyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

3-{4-chloro-3-[2-(methoxymethyl)-2H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[1-(methoxymethyl)-1H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[2-(ethoxymethyl)-2H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[1-(ethoxymethyl)-1H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[3-(2-allyl-2H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[3-(1-allyl-1H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-2-fluoro-5-[(5-methyl-1,2,4-oxadiazol-3-yl) methoxy]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{2,4-dichloro-5-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-2-fluoro-5-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-2-fluoro-5-(1,2,4-oxadiazol-3-ylmethoxy)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[3-(2-tert-butyl-2H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-(4-chloro-3-{2-[(2-methoxyethoxy)methyl]-2H-tetrazol-5-yl}phenyl)-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-(4-chloro-3-{1-[(2-methoxyethoxy)methyl]-1H-tetrazol-5-yl}phenyl)-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[4-chloro-3-(2-isopropyl-2H-tetrazol-5-yl)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[3-(2-benzyl-2H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(3H)-pyrimidinedione;

3-[3-(1-benzyl-1H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

methyl (2E)-4-{2-chloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4 (trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate;

ethyl (2E)-4-{2-chloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4 (trifluoromethyl) pyrimidin-1-yl]phenoxy}-3-ethoxybut-2-enoate;

3-[4-chloro-3-(1,2,4-oxadiazol-3-ylmethoxy)phenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[1-(cyclopropylmethyl)-1H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[2-(cyclopropylmethyl)-2H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-[3-(2-butyl-2H-tetrazol-5-yl)-4-chlorophenyl]-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-(4-chloro-3-{2-[(4-chlorophenoxy)methyl]-2H-tetrazol-5-yl}phenyl)-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-(4-chloro-3-{1-[(4-chlorophenoxy)methyl]-1H-tetrazol-5-yl}phenyl)-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[2-(4-chlorobenzyl)-2H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

3-{4-chloro-3-[1-(4-chlorobenzyl)-1H-tetrazol-5-yl]phenyl}-1-methyl-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione;

methyl 2-{2-chloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenyl}-1,3-thiazole-4-carboxylate;

methyl (2-{2-chloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenyl}-1,3-thiazol-4-yl)acetate.

3. A herbicidal composition containing, as active principle, an effective amount of one or more compounds having formula (I) according to claim 1 and a non-phytotoxic carrier.

4. The herbicidal composition according to claim 3 , characterized in that the concentration of the active substance ranges from 1 to 90%.

5. A compound as defined in claim 1 wherein Q is 1,2,4-oxadiazolyl.

6. A compound as defined in claim 1 wherein Q is 5-methyl-1,2,4-oxadiazolyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2012
From: ISAGRO S.P.A.
To: ISEM S.R.L.
Reel/Frame 027469/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2011
From: ISAGRO RICERCA S.R.L.
To: ISAGRO S.P.A.
Reel/Frame 026425/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2005
From: MEAZZA, GIOVANNI; PARAVIDINO, PIERO; BETTARINI, FRANCO; FORNARA, LUCA
To: ISAGRO RICERCA S.R.L.
Reel/Frame 017078/0853 →
Priority Claims (1)
IT MI2002A2758 · Dec 23, 2002 · national
Continuity (1)
Related Publication 20060025591A1 · Feb 2, 2006